Trial Profile
Prospective, randomised, multicentre controlled trial on empiric antibiotic therapy in febrile neutropenic cancer patients: piperacillin and tazobactam plus tigecycline versus piperacillin or tazobactam monotherapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Oct 2016
Price :
$35
*
At a glance
- Drugs Tigecycline (Primary) ; Piperacillin; Piperacillin/tazobactam; Tazobactam
- Indications Bacterial infections
- Focus Therapeutic Use
- 19 Jul 2012 New source identified and integrated (ISRCTN: Current Controlled Trials 00586497)
- 11 Oct 2011 New trial record